PLA2: A Protein Involved in Cell Signaling and Disease (P12624)

Target Name: Phospholipase A2, Secretory (sPLA2)

NCBI ID: P12624

Phospholipase A2, Secretory (sPLA2)

Other Name(s): None

PLA2: A Protein Involved in Cell Signaling and Disease

Phospholipase A2 (PLA2), also known as secretory (sPLA2) (nonspecified subtype), is a protein that is expressed in various cell types throughout the body. It is a potent enzyme that is involved in the breakdown of phospholipids, which are a vital component of cell membranes. PLA2 is highly expressed in tissues that are rich in lipids, such as the brain, heart, and liver.

PLA2 is also involved in the regulation of cellular signaling pathways, including the production of neurotransmitters, such as serotonin and dopamine. It has been shown to play a critical role in the regulation of pain signaling and the modulation of neurotransmitter release.

Despite its importance, PLA2 has until now been little understood. However, recent studies have identified several potential drug targets and biomarkers that may be associated with PLA2.

One potential drug target for PLA2 is the inhibition of PLA2 activity. Activated PLA2 has been shown to contribute to the development of neurodegenerative diseases, including Alzheimer's disease and Parkinson's disease. Therefore, inhibitors of PLA2 have been shown to be effective in treating these conditions.

Another potential drug target for PLA2 is the modulation of PLA2 expression. Many diseases, including neurodegenerative diseases, are characterized by the misregulation of PLA2 activity. Therefore, drugs that can modulate PLA2 expression levels could be effective in treating these conditions.

In addition to its potential drug targets, PLA2 is also a potential biomarker for various diseases. The breakdown of phospholipids by PLA2 has been shown to be altered in a variety of diseases, including neurodegenerative diseases, cancer, and cardiovascular disease. Therefore, the levels of PLA2 expression in these diseases may be a useful biomarker for diagnostic purposes.

Overall, PLA2 is a protein that has significant implications for our understanding of cellular signaling pathways and the regulation of various diseases. Further research is needed to fully understand its role in the regulation of cellular processes and its potential as a drug target and biomarker.

Protein Name: Phospholipase A2, Secretory (sPLA2) (nonspecified Subtype)

The "Phospholipase A2, Secretory (sPLA2) Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about Phospholipase A2, Secretory (sPLA2) comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets